158 related articles for article (PubMed ID: 3585445)
1. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma.
Fuller DB; Sause WT; Plenk HP; Menlove RL
J Clin Oncol; 1987 Jun; 5(6):897-905. PubMed ID: 3585445
[TBL] [Abstract][Full Text] [Related]
2. Postoperative radiation therapy for epithelial ovarian cancer: the curative role based on a 24-year experience.
Martinez A; Schray MF; Howes AE; Bagshaw MA
J Clin Oncol; 1985 Jul; 3(7):901-11. PubMed ID: 3926956
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer.
Cmelak AJ; Kapp DS
Gynecol Oncol; 1997 Jun; 65(3):453-60. PubMed ID: 9190975
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy.
Kapp KS; Kapp DS; Poschauko J; Stücklschweiger GF; Hackl A; Pickel H; Petru E; Winter R
Gynecol Oncol; 1999 Sep; 74(3):400-7. PubMed ID: 10479500
[TBL] [Abstract][Full Text] [Related]
5. [Abdominopelvic radiation therapy in the treatment of ovarian carcinoma. Study of a continuous series of 167 patients].
Thomas L; Pigneux J; Chauvergne J; Stöckle E; Bussières E; Chemin A; Toulouse C
Bull Cancer Radiother; 1994; 81(1):23-31. PubMed ID: 7893520
[TBL] [Abstract][Full Text] [Related]
6. [Postoperative radiotherapy of epithelial ovarian cancers].
Kucera H; Sevelda P; Genger H; Weghaupt K
Geburtshilfe Frauenheilkd; 1985 Dec; 45(12):848-52. PubMed ID: 4085759
[TBL] [Abstract][Full Text] [Related]
7. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
[TBL] [Abstract][Full Text] [Related]
8. Use of P-32 in stage III epithelial carcinoma of the ovary.
Spanos WJ; Day T; Jose B; Paris K; Lindberg RD
Gynecol Oncol; 1994 Jul; 54(1):35-9. PubMed ID: 8020836
[TBL] [Abstract][Full Text] [Related]
9. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?
Skirnisdottir I; Nordqvist S; Sorbe B
Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
Varia MA; Stehman FB; Bundy BN; Benda JA; Clarke-Pearson DL; Alvarez RD; Long HJ;
J Clin Oncol; 2003 Aug; 21(15):2849-55. PubMed ID: 12885800
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of high dose abdominopelvic radiotherapy following surgery and chemotherapy for stage III epithelial carcinoma of the ovary.
Coltart RS; Nethersell AB; Brown CH
Gynecol Oncol; 1986 Jan; 23(1):105-10. PubMed ID: 3510945
[TBL] [Abstract][Full Text] [Related]
12. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of whole abdominal irradiation in ovarian carcinoma with a four orthogonal fields technique.
Thomas L; Pigneux J; Chauvergne J; Stöckle E; Bussières E; Chemin A; Toulouse C
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1083-90. PubMed ID: 7961015
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary report.
Arian-Schad KS; Kapp DS; Hackl A; Juettner FM; Leitner H; Porsch G; Lahousen M; Pickel H
Gynecol Oncol; 1990 Oct; 39(1):47-55. PubMed ID: 2227572
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of postoperative irradiation in patients with early-stage ovarian cancer.
Leers WH; Kock HC
Gynecol Oncol; 1987 Sep; 28(1):41-9. PubMed ID: 3653769
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked Stage I, II, and III ovarian cancer.
Fyles AW; Thomas GM; Pintilie M; Ackerman I; Levin W
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):543-9. PubMed ID: 9635700
[TBL] [Abstract][Full Text] [Related]
17. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
20. Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer.
Rothenberg ML; Ozols RF; Glatstein E; Steinberg SM; Reed E; Young RC
J Clin Oncol; 1992 May; 10(5):727-34. PubMed ID: 1569445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
